Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 8, 2007 - Issue 10
Submit an article Journal homepage
339
Views
22
CrossRef citations to date
0
Altmetric
Review

Bacterial meningitis: a review of effective pharmacotherapy

Martijn Weisfelt Neurologist, Academic Medical Centre, Department of Neurology, Centre of Infection and Immunity Amsterdam (CINIMA), PO Box 22660, 1100 DD Amsterdam, The Netherlands +31 20 5663842; +31 20 5669217; [email protected]
, MD PhD,
Jan de Gans Neurologist, Academic Medical Centre, Department of Neurology, Centre of Infection and Immunity Amsterdam (CINIMA), PO Box 22660, 1100 DD Amsterdam, The Netherlands +31 20 5663842; +31 20 5669217; [email protected]
, MD PhD &
Diederik van de Beek Neurologist, Academic Medical Centre, Department of Neurology, Centre of Infection and Immunity Amsterdam (CINIMA), PO Box 22660, 1100 DD Amsterdam, The Netherlands +31 20 5663842; +31 20 5669217; [email protected]
, MD PhD
Pages 1493-1504 | Published online: 30 Jul 2007

Bibliography

  • TUNKEL AR: Bacterial Meningitis. Lippincott Williams & Wilkinson, Philadelphia (2001).
  • HAUSDORFF WP, FEIKIN DR, KLUGMAN KP: Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. (2005) 5:83-93.
  • SWARTZ MN: Bacterial meningitis – a view of the past 90 years. N. Engl. J. Med. (2004) 351:1826-1828.
  • VAN DE BEEK D, DE GANS J, TUNKEL AR, WIJDICKS EF: Community-acquired bacterial meningitis in adults. N. Engl. J. Med. (2006) 354:44-53.
  • SCHUCHAT A, ROBINSON K, WENGER JD et al.: Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. (1997) 337:970-976.
  • DURAND ML, CALDERWOOD SB, WEBER DJ et al.: Acute bacterial meningitis in adults. A review of 493 episodes. N. Engl. J. Med. (1993) 328:21-28.
  • VAN DE BEEK D, DE GANS J, SPANJAARD L, WEISFELT M, REITSMA JB, VERMEULEN M: Clinical features and prognostic factors in adults with bacterial meningitis. N. Engl. J. Med. (2004) 351:1849-1859.
  • SAEZ-LLORENS X, MCCRACKEN GH Jr: Bacterial meningitis in children. Lancet (2003) 361:2139-2148.
  • PELTOLA H: Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin. Microbiol. Rev. (2000) 13:302-317.
  • SHORT WR, TUNKEL AR: Changing epidemiology of bacterial meningitis in the United States. Curr. Infect. Dis. Rep. (2000) 2:327-331.
  • FITCH MT, VAN DE BEEK D: Emergency diagnosis and treatment of adult meningitis. Lancet Infect. Dis. (2007) 7:191-200.
  • KYAW MH, LYNFIELD R, SCHAFFNER W et al.: Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. (2006) 354:1455-1463.
  • SNAPE MD, POLLARD AJ: Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect. Dis. (2005) 5:21-30.
  • WHITNEY CG, FARLEY MM, HADLER J et al.: Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. (2000) 343:1917-1924.
  • BUTLER JC, DOWELL SF, BREIMAN RF: Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention. Vaccine (1998) 16:1693-1697.
  • WEISFELT M, DE GANS J, VAN DER POLL T, VAN DE BEEK D: Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol. (2006) 5:332-342.
  • KASTENBAUER S, PFISTER HW: Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain (2003) 126:1015-1025.
  • BRUYN GA, KREMER HP, DE MARIE S, PADBERG GW, HERMANS J, VAN FURTH R: Clinical evaluation of pneumococcal meningitis in adults over a twelve-year period. Eur. J. Clin. Microbiol. Infect. Dis. (1989) 8:695-700.
  • HOEN B, VIEL JF, GERARD A, DUREUX JB, CANTON P: Mortality in pneumococcal meningitis: a multivariate analysis of prognostic factors. Eur. J. Med. (1993) 2:28-32.
  • AUBURTIN M, PORCHER R, BRUNEEL F et al.: Pneumococcal meningitis in the intensive care unit: prognostic factors of clinical outcome in a series of 80 cases. Am. J. Respir. Crit. Care Med. (2002) 165:713-717.
  • ATTIA J, HATALA R, COOK DJ, WONG JG: The rational clinical examination. Does this adult patient have acute meningitis? JAMA (1999) 282:175-181.
  • VAN DE BEEK D, SCHMAND B, DE GANS J et al.: Cognitive impairment in adults with good recovery after bacterial meningitis. J. Infect. Dis. (2002) 186:1047-1052.
  • HOOGMAN M, VAN DE BEEK D, WEISFELT M, DE GANS J, SCHMAND B: Cognitive outcome in adults after bacterial meningitis. J. Neurol. Neurosurg. Psychiatry (In Press) (E-pub).
  • PROULX N, FRECHETTE D, TOYE B, CHAN J, KRAVCIK S: Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM (2005) 98:291-298.
  • ARONIN SI, PEDUZZI P, QUAGLIARELLO VJ: Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann. Intern. Med. (1998) 129:862-869.
  • AUBURTIN M, WOLFF M, CHARPENTIER J et al.: Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit. Care Med. (2006) 34:2758-2765.
  • VAN DE BEEK D, DE GANS J, SPANJAARD L, VERMEULEN M, DANKERT J: Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J. Antimicrob. Chemother. (2002) 49:661-666.
  • LUTSAR I, MCCRACKEN GH JR, FRIEDLAND IR: Antibiotic pharmacodynamics in cerebrospinal fluid. Clin. Infect. Dis. (1998) 27:1117-1127.
  • ANDES DR, CRAIG WA: Pharmacokinetics and pharmacodynamics of antibiotics in meningitis. Infect. Dis. Clin. North Am. (1999) 13:595-618.
  • SCHMIDT T, TAUBER MG: Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations. J. Antimicrob. Chemother. (1993) 31(Suppl. D):61-70.
  • SINNER SW, TUNKEL AR: Antimicrobial agents in the treatment of bacterial meningitis. Infect. Dis. Clin. North Am (2004) 18:581-602.
  • VAN DE BEEK D, DE GANS J: Dexamethasone in adults with community-acquired bacterial meningitis. Drugs (2006) 66:415-427.
  • KOEDEL U, SCHELD WM, PFISTER HW: Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect. Dis. (2002) 2:721-736.
  • AKIRA S: Toll-like receptors and innate immunity. Adv. Immunol. (2001) 78:1-56.
  • MATTIE DH, STUERTZ K, NAU R, VAN DISSEL JT: Pharmacodynamics of antibiotics with respect to bacterial killing of and release of lipoteichoic acid by Streptococcus pneumoniae. J. Antimicrob. Chemother. (2005) 56(1):154-159.
  • BRINK M, HAGBERG L: Outcome of 8-hour dosing intervals with β-lactam antibiotics in adult acute bacterial meningitis. Scand. J. Infect. Dis. (2006) 38:772-777.
  • ROBERTS JA, BOOTS R, RICKARD CM et al.: Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study. J. Antimicrob. Chemother. (2007) 59:285-291.
  • TUNKEL AR, HARTMAN BJ, KAPLAN SL et al.: Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. (2004) 39:1267-1284.
  • PFAUSLER B, SPISS H, BEER R et al.: Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J. Neurosurg. (2003) 98:1040-1044.
  • MCCRACKEN GH JR, MIZE SG: A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the Neonatal Meningitis Cooperative Study Group. J. Pediatr. (1976) 89:66-72.
  • MCCRACKEN GH JR, MIZE SG, THRELKELD N: Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet (1980) 1:787-791.
  • MANDEL G, BENNETT J, DOLIN R: Principles and Practice of Infectious Diseases (6 edn). Churchill Livingston, New York (2005).
  • LATORRE C, GENE A, JUNCOSA T, MUNOZ C, GONZALEZ-CUEVAS A: Neisseria meningitidis: evolution of penicillin resistance and phenotype in a children's hospital in Barcelona, Spain. Acta Paediatr. (2000) 89:661-665.
  • CUBELLS CL, GARCIA JJG, MARTINEZ JR, OTIN CL: Clinical data in children with meningococcal meningitis in a Spanish hospital. Acta Paediatr. (1997) 86:26-29.
  • SCHELD WM, DACEY RG, WINN HR, WELSH JE, JANE JA, SANDE MA: Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone. J. Clin. Invest. (1980) 66:243-253.
  • TAUBER MG, KHAYAM-BASHI H, SANDE MA: Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J. Infect. Dis. (1985) 151:528-534.
  • SCHELD WM, KOEDEL U, NATHAN B, PFISTER HW: Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J. Infect. Dis. (2002) 186(Suppl. 2):S225-S233.
  • VAN DE BEEK D, DE GANS J, MCINTYRE P, PRASAD K: Corticosteroids for acute bacterial meningitis. Cochrane Database Syst. Rev. (2007) (1):CD004405.
  • MCINTYRE PB, BERKEY CS, KING SM et al.: Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA (1997) 278:925-931.
  • DE GANS J, VAN DE BEEK D: Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. (2002) 347:1549-1556.
  • VAN DE BEEK D, DE GANS J: Dexamethasone and pneumococcal meningitis. Ann. Intern. Med. (2004) 141:327.
  • VAN DE BEEK D, DE GANS J, MCINTYRE P, PRASAD K: Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect. Dis. (2004) 4:139-143.
  • WEISFELT M, VAN DE BEEK D, DE GANS J: Dexamethasone treatment in adults with pneumococcal meningitis: risk factors for death. Eur. J. Clin. Microbiol. Infect. Dis. (2006) 25(2):73-78.
  • VAN DE BEEK D: The brainteasing effect of dexamethasone. Lancet Neurol. Dis. (2007) 6:203-204.
  • ANNANE D, SEBILLE V, CHARPENTIER C et al.: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA (2002) 288:862-871.
  • COOPER MS, STEWART PM: Corticosteroid insufficiency in acutely ill patients. N. Engl. J. Med. (2003) 348:727-734.
  • CRONIN L, COOK DJ, CARLET J, HEYLAND DK et al.: Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit. Care Med. (1995) 23:1430-1439.
  • PARIS MM, HICKEY SM, USCHER MI, SHELTON S, OLSEN KD, MCCRACKEN GH JR: Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. (1994) 38:1320-1324.
  • RICARD JD, WOLFF M, LACHERADE JC et al.: Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin. Infect. Dis. (2007) 44:250-255.
  • LEIB SL, HEIMGARTNER C, BIFRARE YD, LOEFFLER JM, TAAUBER MG: Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr. Res. (2003) 54:353-357.
  • SPREER A, GERBER J, HANSSEN MS et al.: Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis. Pediatr. Res. (2006) 60:210-215.
  • WEISFELT M, HOOGMAN M, VAN DE BEEK D, DE GANS J, DRESCHLER WA, SCHMAND BA: Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann. Neurol. (2006) 60:456-468.
  • BUTLER JC, SHAPIRO ED, CARLONE GM: Pneumococcal vaccines: history, current status, and future directions. Am. J. Med. (1999) 107:S69-S76.
  • SWIATLO E, WARE D: Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS Immunol. Med. Microbiol. (2003) 38:1-7.
  • KNAUST A, FROSCH M: Genome-based vaccines. Int. J. Med. Microbiol. (2004) 294:295-301.
  • KIM KS: Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat. Rev. Neurosci. (2003) 4:376-385.
  • VAN DE BEEK D, WEISFELT M, DE GANS J, TUNKEL AR, WIJDICKS EF: Drug insight: adjunctive therapies in adults with bacterial meningitis. Nat. Clin. Pract. Neurol. (2006) 2:504-516.
  • KASTENBAUER S: Pneumococcal meningitis: a 21st century perspective. Lancet Neurol. (2006) 5:104-105.
  • WEISFELT M, VAN DE BEEK D, SPANJAARD L, REITSMA JB, DE GANS J: Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. (2006) 5:123-129.
  • WEISFELT M, VAN DE BEEK D, SPANJAARD L, REITSMA JB, DE GANS J: Community-acquired bacterial meningitis in older people. J. Am. Geriatr. Soc. (2006) 54:1500-1507.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.